FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

79605009: 3 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    132068015 Three en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442100016 3 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442101017 3 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3912381000005116 tre da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) dansk modul

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    tre Is a General adjectival modifier false Inferred relationship Some
    tre Is a tal false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Bromazepam 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Auranofin 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Hydromorphone hydrochloride 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Auranofin 3 mg oral capsule Has presentation strength numerator value False tre Inferred relationship Some 1
    Warfarin sodium 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Risperidone 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule Has presentation strength numerator value False tre Inferred relationship Some 1
    Oxybutynin hydrochloride 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Ivermectin 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    ropinirol 3 mg tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    flupentixol 3 mg tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Glimepiride 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Glibenclamide micronised 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Estropipate 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 2
    ethinylestradiol 30 µg + drospirenon 3 mg tablet Has presentation strength numerator value False tre Inferred relationship Some 2
    Eszopiclone 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Doxepin 3 mg oral tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Dinoprostone 3 mg vaginal tablet Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely prochlorperazine maleate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    abacavirsulfat 300 mg + lamivudin 150 mg + zidovudin 300 mg tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule Count of base of active ingredient False tre Inferred relationship Some
    dehydrocholsyre 180 mg + dimethicon 40 mg + pancreatin 300 mg tablet Count of base of active ingredient False tre Inferred relationship Some
    Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Count of base of active ingredient False tre Inferred relationship Some
    Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Count of base of active ingredient False tre Inferred relationship Some
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Count of base of active ingredient False tre Inferred relationship Some
    ceftazidim 3 g pulver til injektionsvæske, opløsning, hætteglas Has presentation strength numerator value False tre Inferred relationship Some 1
    Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 1
    Prednisolone 3 mg/mL oral solution Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 1
    Ephedrine hydrochloride 3 mg/mL oral solution Has concentration strength numerator value False tre Inferred relationship Some 1
    gentamicin 0,3 % øjen-/øredråber Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Hydroxypropyl methylcellulose 0.32% conventional release eye drops Has concentration strength numerator value False tre Inferred relationship Some 1
    Hypromellose 3 mg/mL eye drops Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False tre Inferred relationship Some
    Diflucortolone valerate 3 mg/g cutaneous ointment Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 1
    Heparinoid 3 mg/g cutaneous cream Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 2
    Diflucortolone valerate 3 mg/g cutaneous cream Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) Has concentration strength numerator value False tre Inferred relationship Some 1
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has concentration strength numerator value False tre Inferred relationship Some 1
    Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely disodium pamidronate 60 milligram/20 milliliter conventional release solution for injection vial Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely disodium pamidronate 90 milligram/30 milliliter conventional release solution for injection vial Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely ephedrine hydrochloride 30 milligram/10 milliliter conventional release solution for injection ampule Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False tre Inferred relationship Some 1
    Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream Has concentration strength numerator value False tre Inferred relationship Some 2
    Product containing precisely adenosine 30 milligram/10 milliliter conventional release solution for infusion vial Has concentration strength numerator value False tre Inferred relationship Some 1
    Product containing precisely adenosine 6 milligram/2 milliliter conventional release solution for injection vial Has concentration strength numerator value False tre Inferred relationship Some 1

    Page 1 of 5 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start